Daewoong Pharmaceutical announces success in developing a new antidiabetic medication and its aims to enter the market in over 50 countries by 2030

PR Newswire
December 6, 2022 — 20:00 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: brazil China Expansion healthcare insurance medicine pharmaceutical Saudi Arabia South Korea

Related News:

Zepp Health Corporation Files 2023 Annual Report on Form 20-F

April 23, 2024 — 20:20

TTC Announces Strategic Expansion into Western Australia with New Perth Office

April 23, 2024 — 04:00

Latham Adds Experienced M&A Partner in Tokyo

April 23, 2024 — 03:15

GT20029 China Phase II Trial For AGA Reached Primary Endpoint

April 22, 2024 — 09:53

Mayur achieves major milestone with US$155 million for Central Lime Project in Papua New Guinea

April 22, 2024 — 09:38

Four World Records Set Weichai Power Unveils World’s First Diesel Engine with 53.09% Thermal Efficiency

April 20, 2024 — 20:19

Four World Records Set Weichai Power Unveils World’s First Diesel Engine with 53.09% Thermal Efficiency

April 20, 2024 — 19:58

ASTRI’s Wins 23 Awards Geneva Inventions Expo

April 20, 2024 — 16:31

Inaugural ‘Korea Medical Innovation Research Forum’ regular seminar, a success

April 19, 2024 — 21:00